Yayınlar & Eserler

Yayın Ağı
Makaleler 27
Tümü (27)
SCI-E, SSCI, AHCI (22)
SCI-E, SSCI, AHCI, ESCI (23)
ESCI (1)
Scopus (27)
TRDizin (8)

1. Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

Ulukoylu Menguc M., Arikan F., Aytan P., Bekoz H. S., Hunutlu F. C., Keklik Karadag F., et al.
Journal of Clinical Medicine , cilt.15, sa.16, 2026 (SCI-Expanded, Scopus)

2. Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review

ÖZMEN İBİŞ D., Kürekçi D. D., ÖZKOCAMAN V., Altındağ Avcı B., Bozer D. S., Kasar M., et al.
Leukemia Research , cilt.166, 2026 (SCI-Expanded, Scopus)

3. Analytical Performance and Inter-Method Agreement of a Laboratory-Developed CMV qPCR Assay in Clinical Plasma Samples

Aral M., BAKIR A., Çiçek C., Güner E. T., Özkan D., Kürkçü M. F., et al.
Microorganisms , cilt.14, sa.5, 2026 (SCI-Expanded, Scopus)

4. Inter-Method Agreement of a Laboratory-Developed Qualitative CMV PCR Assay Across Multiple Non-Plasma Clinical Specimens

Aral M., BAKIR A., Çiçek C., Güner E. T., Özkan D., Yağız G. C., et al.
Viruses , cilt.18, sa.4, 2026 (SCI-Expanded, Scopus)

5. Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data

Kilic Gunes E., YAVAŞOĞLU F., Kucukyurt S., Aykas F., YİĞİT KAYA S., YILMAZ İ., et al.
Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.1, ss.82-92, 2026 (SCI-Expanded, Scopus)

6. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

ATAŞ Ü., ILTAR U., YÜCEL O. K., Salur H., BİLEK M. Ç., Ustabas T., et al.
Journal of Clinical Medicine , cilt.14, sa.20, 2025 (SCI-Expanded, Scopus) Creative Commons License

7. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Küçükyurt S., Koca O., TERZİ DEMİRSOY E., AKIN S., DOĞAN A. A., Gören D., et al.
Annals of Hematology , cilt.104, sa.9, ss.4679-4690, 2025 (SCI-Expanded, Scopus)

8. Different Presentations and Different Treatment Options in Blastic Plasmacytoid Dendritic Cell Neoplasms: A Case Series

Cengiz E., Aydin M. S., GÜNEŞ A. K., CERAN F., DAĞDAŞ S., Ozet G.
International Journal of Hematology-Oncology and Stem Cell Research , cilt.19, sa.1, ss.81-85, 2025 (Scopus)

9. Clinical characteristics and outcomes in Epstein–Barr virus-positive diffuse large B-cell lymphoma: a multicenter retrospective study

Kiliç Güneş E., AFACAN ÖZTÜRK H. B., Kiriktir E., Dikyar A., Uğur B., GÜNEŞ A. K., et al.
Turkish Journal of Medical Sciences , cilt.55, sa.5, ss.1113-1121, 2025 (SCI-Expanded, Scopus, TRDizin)

10. Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study

Kilic Gunes E., Savas E. M., Erdogdu B., Gorduk U., Gul D., AFACAN ÖZTÜRK H. B., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.35, sa.3, ss.212-220, 2025 (SCI-Expanded, Scopus, TRDizin)

11. Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma

Korkmaz G., CERAN F., DAĞDAŞ S., GÜNEŞ A. K., Sunu C., Pepeler M., et al.
Nigerian Journal of Clinical Practice , cilt.27, sa.8, ss.1012-1019, 2024 (SCI-Expanded, Scopus)

12. Effect of Mobilization Methods on CD34+ and Total Nucleated Cell Count and Their relation with Engraftment in Autologous Hematopoietic Stem Cell Transplantation

Beyler Ö., Pamukcuoğlu M., GÜNEŞ A. K., Korkmaz G., Ulusoy G., CERAN F., et al.
Eastern Journal of Medicine , cilt.29, sa.3, ss.344-348, 2024 (Scopus, TRDizin)

13. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis Proteazom İnhibitörleri ve İmmünomodülatör Ajanlar Çağında Primer Plazma Hücreli Lösemili Hastaların Sağkalım Sonuçları: Gerçek Yaşam Verilerinden Çok Merkezli Bir Analiz

ATAŞ Ü., SALİM O., ILTAR U., YÜCEL O. K., Eroğlu A. H. K., Aslan V., et al.
Turkish Journal of Hematology , cilt.41, sa.4, ss.225-235, 2024 (SCI-Expanded, Scopus, TRDizin)

14. Mean platelet volume and platelet distribution width in the prediction of treatment response in immune thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a multicenter study

Sayın S., YILDIRIM M., GÜNEŞ A. K., Aras M. R., Yılmaz E. Ş., ALBAYRAK M., et al.
Gulhane Medical Journal , cilt.66, sa.1, ss.43-48, 2024 (Scopus, TRDizin)

15. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry

Ozdemir Z. N., Falay M., Parmaksiz A., Genc E., Beyler O., GÜNEŞ A. K., et al.
Hematology, Transfusion and Cell Therapy , cilt.45, sa.2, ss.176-181, 2023 (ESCI, Scopus)

16. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Uncu Ulu B., DAL M. S., Yönal Hindilerden İ., Akay O. M., MEHTAP Ö., BÜYÜKKURT N., et al.
Journal of Chemotherapy , cilt.34, sa.3, ss.190-198, 2022 (SCI-Expanded, Scopus)

17. Comparison of MitoxantroneeMelphalan and BEAM Conditioning Regimens in Patients with Lymphoma

GÜNEŞ A. K., Serin I., Demir I., Sarifakiogullari S., Durusoy S. S., Akkurt D. M., et al.
Hematology/ Oncology and Stem Cell Therapy , cilt.15, sa.4, ss.201-207, 2022 (Scopus)

18. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study

Akay O. M., Ozbalak M., Pehlivan M., Yildiz B., UZAY A., YİĞENOĞLU T. N., et al.
Hematological Oncology , cilt.39, sa.4, ss.498-505, 2021 (SCI-Expanded, Scopus)

19. A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

GEMİCİ A., ÖZKALEMKAŞ F., Dogu M. H., Tekinalp A., Alacacioglu I., GÜNEY T., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.21, sa.8, 2021 (SCI-Expanded, Scopus)

20. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data Kronik Lenfositik Lösemili Hastalarda İbrutinib Tedavisinin Etkililiği ve Güvenilirliği: Gerçek Hayat Verilerinin Retrospektif Analizi

Tombak A., Tanrıkulu F. P., Durusoy S. S., DİNÇYÜREK H. D., KAYA E., ÜMİT E. G., et al.
Turkish Journal of Hematology , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded, Scopus, TRDizin)

21. Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML

Ucar M., Ozet G., Koyuncu M., SÖNMEZ M., Akidan O., AYLI M. D., et al.
European Review for Medical and Pharmacological Sciences , cilt.25, sa.21, ss.6557-6565, 2021 (SCI-Expanded, Scopus)

22. The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis

Sunu C., GÜNEŞ A. K., Akat G. K., Kalpakci Y., CERAN F., DAĞDAŞ S., et al.
Revista da Associacao Medica Brasileira , cilt.67, sa.3, ss.385-389, 2021 (SCI-Expanded, Scopus)

23. Who 2016 prefibrotic myelofibrosis in the patients with who 2008 essential thrombocythemia

AKTİMUR S. H., Bayçelebi D., GÜNEŞ A. K., Yıldız L., TURGUT M.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.31, sa.3, ss.139-145, 2021 (SCI-Expanded, Scopus, TRDizin)

24. Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE

GÜNEŞ A. K., DAĞDAŞ S., CERAN F., Ucar M. A., Falay M., Sunu C., et al.
Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.82-89, 2021 (SCI-Expanded, Scopus)

25. Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality

DAĞDAŞ S., Ucar M. A., CERAN F., GÜNEŞ A. K., Falay M., Ozet G.
Transfusion and Apheresis Science , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

26. The assessment of the relationship between abo blood groups and COVID-19 infection

AKTİMUR S. H., Sen A., Yazicioglu B., GÜNEŞ A. K., Genc S.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.30, sa.3, ss.121-125, 2020 (SCI-Expanded, Scopus, TRDizin)

27. CD38 expression and variation as a prognostic factor chronic lymphocytic leukemia

Falay M., CERAN F., GÜNEŞ A. K., DAĞDAŞ S., AYLI M., Ozet G.
Clinical Laboratory , cilt.62, sa.7, ss.1287-1293, 2016 (SCI-Expanded, Scopus)
Metrikler

Yayın

27

Yayın (WoS)

23

Yayın (Scopus)

27

H-İndeks (WoS)

6

Atıf (Scopus)

98

H-İndeks (Scopus)

7

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

1

Tez Danışmanlığı

1

Açık Erişim

2